SIGY · Sigyn Therapeutics, Inc.

Summary

Sigyn Therapeutics, Inc. entered into a one-year Convertible Note Purchase Agreement on February 12, 2026, constituting a material definitive agreement and involving an unregistered sale of securities. The agreement is detailed in Exhibit 99.1.

Key takeaways

• Entered Convertible Note Purchase Agreement on 2026-02-12
• Agreement term: one-year
• Item 1.01: Material Definitive Agreement
• Item 3.02: Unregistered Sale of Securities
• Exhibit 99.1: Convertible Note Purchase Agreement